Diaphin 10 g i.v.

Diaphin 10 g i.v. is a medicine authorised by Swissmedic under authorisation number 55561. The authorisation holder is Sandoz Pharmaceuticals AG. The medicinal product code is Synthetic medicines and the dispensing category is A+: Supplied only against a single-use prescription with additional Swissmedic conditions, for example narcotics or medicines with mandatory educational material. First authorisation was granted on 07 December 2001 and the authorisation is valid without a time limit. ATC code N07BC06 places the medicine in the group Other nervous system drugs.

  • Dispensing category A+
  • Authorisation number 55561
  • ATC N07BC06
  • Synthetic medicines
Authorisation data
Authorisation number55561
NameDiaphin 10 g i.v.
Full nameDiaphin 10 g i.v., Pulver zur Herstellung einer Injektionslösung
Authorisation holderSandoz Pharmaceuticals AG
Medicinal product codeSynthetic medicines
Dispensing categoryA+ · Prescription with conditions
ATC codeN07BC06
First authorisation07 December 2001
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
2Diaphin 10 g i.v., Pulver zur Herstellung einer InjektionslösungA+07 December 2001
3Diaphin 5 g i.v., Pulver zur Herstellung einer InjektionslösungA+29 July 2021

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
415Ampulle(n)N07BC0601.01.3.A+
18Ampulle(n)N07BC0601.01.3.A+

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Diaphin 10 g i.v. authorised in Switzerland?

Yes. Diaphin 10 g i.v. is authorised by Swissmedic under authorisation number 55561, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Diaphin 10 g i.v. have?

Diaphin 10 g i.v. is in dispensing category A+. Supplied only against a single-use prescription with additional Swissmedic conditions, for example narcotics or medicines with mandatory educational material.

Who is the authorisation holder of Diaphin 10 g i.v.?

The authorisation holder is Sandoz Pharmaceuticals AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com